147 related articles for article (PubMed ID: 38281442)
21. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
Sakata J; Nomura T; Aono T; Kitami C; Yokoyama N; Minagawa M; Takizawa K; Miura K; Hirose Y; Ichikawa H; Nagahashi M; Shimada Y; Kobayashi T; Wakai T
HPB (Oxford); 2021 Sep; 23(9):1371-1382. PubMed ID: 33558069
[TBL] [Abstract][Full Text] [Related]
22. A Multicenter Survey on Eligibility for a Randomized Phase III Trial of Adjuvant Chemotherapy for Resected Biliary Tract Cancer (JCOG1202, ASCOT).
Kobayashi S; Ikeda M; Nakachi K; Ueno M; Okusaka T; Todaka A; Satoi S; Tomokuni A; Konishi M; Furuse J
Ann Surg Oncol; 2023 Nov; 30(12):7331-7337. PubMed ID: 37450093
[TBL] [Abstract][Full Text] [Related]
23. Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection.
Guglielmi A; Ruzzenente A; Campagnaro T; Pachera S; Valdegamberi A; Nicoli P; Cappellani A; Malfermoni G; Iacono C
World J Surg; 2009 Jun; 33(6):1247-54. PubMed ID: 19294467
[TBL] [Abstract][Full Text] [Related]
24. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis.
Fisher SB; Patel SH; Kooby DA; Weber S; Bloomston M; Cho C; Hatzaras I; Schmidt C; Winslow E; Staley CA; Maithel SK
HPB (Oxford); 2012 Aug; 14(8):514-22. PubMed ID: 22762399
[TBL] [Abstract][Full Text] [Related]
25. Histologic bile duct invasion by a mass-forming intrahepatic cholangiocarcinoma.
Hirohashi K; Uenishi T; Kubo S; Yamamoto T; Tanaka H; Shuto T; Yamasaki O; Horii K; Kinoshita H
J Hepatobiliary Pancreat Surg; 2002; 9(2):233-6. PubMed ID: 12140612
[TBL] [Abstract][Full Text] [Related]
26. Prognosis and prognostic factors in patients with advanced biliary tract cancer depending on its anatomical location.
Song BG; Park JK; Kim HS; Kim K; Park JK; Lee KH; Lee KT; Lee JK
Scand J Gastroenterol; 2019 Jun; 54(6):740-745. PubMed ID: 31136212
[No Abstract] [Full Text] [Related]
27. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
[TBL] [Abstract][Full Text] [Related]
28. [Adjuvant treatment of biliary tract cancers: Who and how?].
Edeline J
Bull Cancer; 2020 Jan; 107(1):48-53. PubMed ID: 31980143
[TBL] [Abstract][Full Text] [Related]
29. Clinical Implications of BRCA Mutations in Advanced Biliary Tract Cancer.
Kim H; Kim JY; Park KU
Oncology; 2023; 101(1):41-48. PubMed ID: 36257294
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant treatment of resectable biliary tract cancer with cisplatin plus gemcitabine: A prospective single center phase II study.
Siebenhüner AR; Seifert H; Bachmann H; Seifert B; Winder T; Feilchenfeldt J; Breitenstein S; Clavien PA; Stupp R; Knuth A; Pestalozzi B; Samaras P
BMC Cancer; 2018 Jan; 18(1):72. PubMed ID: 29325521
[TBL] [Abstract][Full Text] [Related]
31. Locoregional recurrence after curative intent resection for intrahepatic cholangiocarcinoma: implications for adjuvant radiotherapy.
Song S; Kim K; Chie EK; Kim S; Park HJ; Yi NJ; Suh KS; Ha SW
Clin Transl Oncol; 2015 Oct; 17(10):825-9. PubMed ID: 26041722
[TBL] [Abstract][Full Text] [Related]
32. BILCAP trial and adjuvant capecitabine in resectable biliary tract cancer: reflections on a standard of care.
Rizzo A; Brandi G
Expert Rev Gastroenterol Hepatol; 2021 May; 15(5):483-485. PubMed ID: 33307876
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and safety of lenvatinib combined with PD-1/PD-L1 inhibitors plus Gemox chemotherapy in advanced biliary tract cancer.
Zhu C; Xue J; Wang Y; Wang S; Zhang N; Wang Y; Zhang L; Yang X; Long J; Yang X; Sang X; Zhao H
Front Immunol; 2023; 14():1109292. PubMed ID: 36742297
[TBL] [Abstract][Full Text] [Related]
34. Comparison of short- and long-term outcomes between anatomical subtypes of resected biliary tract cancer in a Western high-volume center.
Roos E; Strijker M; Franken LC; Busch OR; van Hooft JE; Klümpen HJ; van Laarhoven HW; Wilmink JW; Verheij J; van Gulik TM; Besselink MG
HPB (Oxford); 2020 Mar; 22(3):405-414. PubMed ID: 31494056
[TBL] [Abstract][Full Text] [Related]
35. [Curative Resection after Chemotherapy for Advanced Extensive Cholangiocarcinoma-A Case Report].
Takagi M; Seyama Y; Takao M; Nakahodo J; Chiba K; Okuya T; Suzuki M; Horiguchi S; Okinaga H; Harada N
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1630-1632. PubMed ID: 38303364
[TBL] [Abstract][Full Text] [Related]
36. The Potential Role of Adjuvant Chemoradiotherapy in Patients with Microscopically Positive (R1) Surgical Margins after Resection of Cholangiocarcinoma.
Palloni A; Bisello S; Maggio I; Massucci M; Galuppi A; Di Federico A; Rizzo A; Ricci AD; Siepe G; Morganti AG; Brandi G; Frega G
Curr Oncol; 2023 May; 30(5):4754-4766. PubMed ID: 37232816
[TBL] [Abstract][Full Text] [Related]
37. Catheter tract recurrence after percutaneous biliary drainage for hilar cholangiocarcinoma.
Kang MJ; Choi YS; Jang JY; Han IW; Kim SW
World J Surg; 2013 Feb; 37(2):437-42. PubMed ID: 23188530
[TBL] [Abstract][Full Text] [Related]
38. Wisteria floribunda agglutinin-sialylated mucin core polypeptide 1 is a sensitive biomarker for biliary tract carcinoma and intrahepatic cholangiocarcinoma: a multicenter study.
Shoda J; Matsuda A; Shida T; Yamamoto M; Nagino M; Tsuyuguchi T; Yasaka T; Tazuma S; Uchiyama K; Unno M; Ohkohchi N; Nakanuma Y; Kuno A; Narimatsu H
J Gastroenterol; 2017 Feb; 52(2):218-228. PubMed ID: 27358229
[TBL] [Abstract][Full Text] [Related]
39. Surgical resection after downsizing chemotherapy for initially unresectable locally advanced biliary tract cancer: a retrospective single-center study.
Kato A; Shimizu H; Ohtsuka M; Yoshidome H; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Kimura F; Miyazaki M
Ann Surg Oncol; 2013 Jan; 20(1):318-24. PubMed ID: 23149849
[TBL] [Abstract][Full Text] [Related]
40. Epidemiologic patterns of biliary tract cancer in the United States: 2001-2015.
Koshiol J; Yu B; Kabadi SM; Baria K; Shroff RT
BMC Cancer; 2022 Nov; 22(1):1178. PubMed ID: 36384474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
